• topiramate 50 mg uses cephalexin prescription cost venlafaxine er 75 mg price clomid pills for pregnancy can bupropion xl 150 mg get you high
  • viagra billigt consommation viagra france cialis erbe cialis en ligne http://bfm.ens-lyon.fr/index.p...a-generico
    kamagra acheter belgique http://lernmodule.zum.de/?comp...tan-recept http://lernmodule.zum.de/?comp...5-apoteket generico cialis en españa farmacia italiana online cialis
    viagra per donne http://tur-reannz1.massey.ac.n...spa%C3%B1a kamagra billigt levitran levitra priser

    Prevalence and Treatment Management of Oropharyngeal Candidiasis in Cancer Patients: Results of the French Candidoscope Study

    Tue, Sep 20, 2011

    Oral Cancer News

    Source: RedJournal.org


    The aim of this pharmaco-epidemiological study was to evaluate the prevalence of oropharyngeal candidiasis (OPC) in cancer patients treated with chemotherapy and/or radiotherapy.

    Methods and Materials

    Signs and symptoms of OPC were noted for all patients. Antifungal therapeutic management was recorded in OPC patients. Patients receiving local antifungal treatments were monitored until the end of treatment.


    Enrolled in the study were 2,042 patients with solid tumor and/or lymphoma treated with chemotherapy and/or another systemic cancer treatment and/or radiotherapy. The overall prevalence of OPC was 9.6% (95% confidence interval, 8.4%–11.0%] in this population. It was most frequent in patients treated with combined chemoradiotherapy (22.0%) or with more than two cytotoxic agents (16.9%). Local antifungal treatments were prescribed in 75.0% of OPC patients as recommended by guidelines. The compliance to treatment was higher in patients receiving once-daily miconazole mucoadhesive buccal tablet (MBT; 88.2%) than in those treated with several daily mouthwashes of amphotericin B (40%) or nystatin (18.8%).


    OPC prevalence in treated cancer patients was high. Local treatments were usually prescribed as per guidelines. Compliance to local treatments was better with once-daily drugs.

    This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

    Print Friendly
    Be Sociable, Share!
    , , , , ,

    Leave a Reply

    You must be logged in to post a comment.